Tag: presentation

MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Emerging Growth Conference

CAMBRIDGE, Mass., June 4, 2026 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that Hyung Heon...

HotSpot Therapeutics Presents Preclinical Data from Small Molecule IRF5 Inhibitor Program at EULAR 2026

BOSTON, June 4, 2026 /PRNewswire/ -- HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, allosteric small molecules that target...

X-energy Reports First Quarter 2026 Results

Shoplazza Helps Australian Merchants Turn Product Ideas Into Ready-to-Sell Online Stores With AI

SYDNEY, June 4, 2026 /PRNewswire/ -- Shoplazza, a global AI-native eCommerce platform, is helping Australian merchants move faster from product idea to online store...

Information to be delivered by Artea Bank at the Nasdaq Vilnius conference “CEO Meets Investors”

ALK will present data on real world-use of nasal adrenaline and key learnings from 20 years with SLIT-tablets at EAACI 2026

At the Annual Congress of the European Academy of Allergy and Clinical Immunology (EAACI) which will this year take part in Istanbul, Türkiye from 12 to 15 June 2026, the Danish pharmaceutical company ALK will present data and key insights within anaphylaxis, food and respiratory allergy.

AbolerIS Pharma Presents New Data Supporting CD45RC as a Novel Therapeutic Target and Potential Biomarker in Sjögren’s Disease at EULAR 2026

- Findings demonstrate strong correlation between CD45RC expression and lymphocytic infiltration in salivary glands, supporting its potential as both an early biomarker and therapeutic...

EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus

BRUSSELS, Belgium and CAMBRIDGE, Mass., June 04, 2026 (GLOBE NEWSWIRE) -- UCB (Euronext Brussels: UCB) and Biogen Inc. (Nasdaq: BIIB) today announced data, comprising two posters and three abstracts, at the European Alliance of Associations for Rheumatology (EULAR) 2026 Congress, demonstrating the clinical profile of dapirolizumab pegol (DZP), an investigational biologic in patients with systemic lupus erythematosus (SLE).

2026 ASCO LBA | Juncell Therapeutics’ GC101 TIL Therapy Achieves Primary Endpoint in the Pivotal Phase II Trial for PD-1 Antibody Failed Advanced Melanoma

SHANGHAI, June 3, 2026 /PRNewswire/ -- On June 1 (Chicago time), in a Late-Breaking Abstract (LBA) oral presentation at the 2026 American Society of Clinical...

POP Biotechnologies Secures Up to $9.7 Million in CEPI Funding

Funding to Propel POP BIO SNAP™ Nanoparticle Vaccine Platform into Phase 1 Clinical Trials in the U.S.

Funding to Propel POP BIO SNAP™ Nanoparticle Vaccine Platform into Phase 1 Clinical Trials in the U.S.

Consumer Watchdog Warns of Continued Gasoline Price Spikes Without Promised Energy Commission Rules

SACRAMENTO, Calif., June 3, 2026 /PRNewswire/ -- Consumer President Jamie Court warned the Senate Energy, Utilities and Commerce Committee today that without long-promised oil...

MILLER INDUSTRIES TO PRESENT AND HOST 1X1 INVESTOR MEETINGS AT THE 16TH ANNUAL EAST COAST IDEAS INVESTOR CONFERENCE ON JUNE 10TH & 11TH IN...

CHATTANOOGA, Tenn., June 3, 2026 /PRNewswire/ -- Miller Industries, Inc. (NYSE: MLR), the World's Largest Manufacturer of Towing and Recovery Equipment, today announced that...

Broadcom Inc. Announces Second Quarter Fiscal Year 2026 Financial Results and Quarterly Dividend

Revenue of $22,187 million for the second quarter, up 48 percent from the prior year periodGAAP net income of $9,310 million for the second...

The Largest IPO in History Is Weeks Away. James Altucher’s Free Presentation Explains Why This Moment Matters.

As SpaceX prepares to list on the Nasdaq in June, the early technology trend spotter walks through the story behind one of the most anticipated public offerings in years.

As SpaceX prepares to list on the Nasdaq in June, the early technology trend spotter walks through the story behind one of the most anticipated public offerings in years.

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsPresentation

WSE Investor News: If You Have Suffered Losses in Wise Group plc (NASDAQ: WSE), You Are Encouraged to Contact The Rosen Law Firm About...

Wells Fargo Foundation Provides $1 Million Grant to Expand Capital Access for Broward County Entrepreneurs

Avicanna Announces Closing of Non-Brokered Private Placement